Evidence map›Paper›PMID 33554093›Full record

ArticleEClinicalMedicine2021

Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders.

F Atiq, J L Saes, M C Punt, K P M van Galen, R E G Schutgens, K Meijer, M H Cnossen, B A P Laros-Van Gorkom, M Peters, L Nieuwenhuizen and 11 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06736158 (Early Genomic Testing for Inherited Bleeding Disorders in Patients Without a Diagnosis After First Line Testing), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06736158 early_phase1recruitingnot on this mapstarted 2025, after this paper: background citation

Early Genomic Testing for Inherited Bleeding Disorders in Patients Without a Diagnosis After First Line Testing: a Randomized Controlled Trial

TypeinterventionalSponsorQueen's UniversityRan2025 to 2027Enrolled212ConditionsBleeding DisorderArmsGenetic testing for inherited bleeding disorders
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Low vitamin C status and hypermobility-related disorders in patients with bleeding disorder of unknown cause.Haemophilia : the official journal of the World Federation of Hemophilia · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Laboratory-based inequity in thrombosis and hemostasis: review of the evidence.Research and practice in thrombosis and haemostasis · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 1 country.

F AtiqDepartment of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
J L SaesHemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, the Netherlands.
M C PuntBenign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht and University Utrecht, Utrecht, the Netherlands.
K P M van GalenBenign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht and University Utrecht, Utrecht, the Netherlands.
R E G SchutgensBenign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht and University Utrecht, Utrecht, the Netherlands.
K MeijerDepartment of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
M H CnossenDepartment of Pediatric Hematology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands.
B A P Laros-Van GorkomHemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, the Netherlands.
M PetersEmma Children's Hospital, Amsterdam UMC, University of Amsterdam, Pediatric-Hematology, Amsterdam, the Netherlands.
L NieuwenhuizenHemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, the Netherlands.
M J H A KruipDepartment of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
J de MerisNetherlands Hemophilia Society, Leiden, the Netherlands.
J G van der BomDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
F J M van der MeerDepartment of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
K FijnvandraatEmma Children's Hospital, Amsterdam UMC, University of Amsterdam, Pediatric-Hematology, Amsterdam, the Netherlands.
I C KruisNetherlands Hemophilia Society, Leiden, the Netherlands.
W L van HeerdeHemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, the Netherlands.
H C J EikenboomDepartment of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
Frank W G LeebeekDepartment of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
S E M ScholsHemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, the Netherlands.
WiN, RBiN and TiN study groups
Radboud University Nijmegen · NLErasmus MC · NLLeiden University Medical Center · NLUniversity Medical Center Utrecht · NLNetherlands Haemophilia SocietyEmma Kinderziekenhuis · NLErasmus MC - Sophia Children’s Hospital · NLSanquin · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, more awareness is raised about sex-specific dilemmas in inherited bleeding disorders. However, no large studies have been performed to assess differences in diagnosis, bleeding phenotype and management of men and women with bleeding disorders. Therefore, we investigated sex differences in a large cohort of well-defined patients with autosomal inherited bleeding disorders (von Willebrand disease (VWD), rare bleeding disorders (RBDs) and congenital platelet defects (CPDs)).

methodsWe included patients from three nationwide cross-sectional studies on VWD, RBDs and CPDs in the Netherlands, respectively the WiN, RBiN and TiN study. In all studies a bleeding score (BS) was obtained, and patients filled in an extensive questionnaire on the management and burden of their disorder.

findingsWe included 1092 patients (834 VWD; 196 RBD; 62 CPD), of whom 665 (60.9%) were women. Women were more often referred because of a bleeding diathesis than men (47.9% vs 36.6%,

interpretationWomen with autosomal inherited bleeding disorders are more often referred for bleeding, have a longer diagnostic delay, and often require treatment because of sex-specific bleeding.

fundingThe WiN study was supported (in part) by research funding from the Dutch Hemophilia Foundation (Stichting Haemophilia), Shire (Takeda), and CSL Behring (unrestricted grant).

Indexed as

Blood platelet disordersHemorrhageHemorrhagic disordersInherited coagulation disordersSex characteristicsvon Willebrand disease

Identifiers

PMID33554093
PMCPMC7848767
OpenAlexW3126284653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.